• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项全基因组关联研究鉴定出甲状腺功能亢进性低钾周期性瘫痪的新易感性遗传变异。

A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis.

机构信息

Endocrine and Metabolism Unit, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Rama 6 Road, Mahidol University, Bangkok, Thailand.

出版信息

J Hum Genet. 2012 May;57(5):301-4. doi: 10.1038/jhg.2012.20. Epub 2012 Mar 8.

DOI:10.1038/jhg.2012.20
PMID:22399142
Abstract

Several lines of evidence have pointed out that genetic components have roles in thyrotoxic hypokalemic periodic paralysis (TTPP). In this study, for the first time we performed genome-wide association study (GWAS) in male hyperthyroid subjects in order to identify genetic loci conferring susceptibility to TTPP. We genotyped 78 Thai male TTPP cases and 74 Thai male hyperthyroid patients without hypokalemia as controls with Illumina Human-Hap610 Genotyping BeadChip. Among the SNPs analyzed in the GWAS, rs312729 at chromosome 17q revealed the lowest P-value for association (P=2.09 × 10(-7)). After fine mapping for linkage disequilibrium blocks surrounding the landmark SNP, we found a significant association of rs623011; located at 75 kb downstream of KCNJ2 on chromosome 17q, reached the GWAS significance after Bonferroni's adjustment (P=3.23 × 10(-8), odds ratio (OR)=6.72; 95% confidence interval (CI)=3.11-14.5). The result was confirmed in an independent cohort of samples consisting of 28 TTPP patients and 48 controls using the same clinical criteria diagnosis (replication analysis P=3.44 × 10(-5), OR=5.13; 95% CI=1.87-14.1; combined-analysis P=3.71 × 10(-12), OR=5.47; 95% CI=3.04-9.83).

摘要

几项研究结果表明,遗传因素在毒性弥漫性甲状腺肿伴低钾周期性瘫痪(TTPP)中起作用。本研究首次对男性甲亢患者进行全基因组关联研究(GWAS),以确定与 TTPP 易感性相关的遗传位点。我们使用 Illumina Human-Hap610 Genotyping BeadChip 对 78 例泰国男性 TTPP 病例和 74 例泰国男性无低钾血症的甲亢患者进行基因分型。在 GWAS 分析的 SNP 中,染色体 17q 上的 rs312729 显示出与关联的最低 P 值(P=2.09×10(-7))。在对 landmark SNP 周围的连锁不平衡块进行精细映射后,我们发现 rs623011 存在显著关联;位于染色体 17q 上 KCNJ2 下游 75kb 处,在经过 Bonferroni 调整后达到 GWAS 显著性(P=3.23×10(-8),优势比(OR)=6.72;95%置信区间(CI)=3.11-14.5)。使用相同的临床标准诊断,在由 28 例 TTPP 患者和 48 例对照组成的独立样本队列中对该结果进行了验证(复制分析 P=3.44×10(-5),OR=5.13;95% CI=1.87-14.1;联合分析 P=3.71×10(-12),OR=5.47;95% CI=3.04-9.83)。

相似文献

1
A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis.一项全基因组关联研究鉴定出甲状腺功能亢进性低钾周期性瘫痪的新易感性遗传变异。
J Hum Genet. 2012 May;57(5):301-4. doi: 10.1038/jhg.2012.20. Epub 2012 Mar 8.
2
Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3.全基因组关联研究在 17q24.3 鉴定出甲状腺功能亢进性周期性瘫痪的易感性位点。
Nat Genet. 2012 Sep;44(9):1026-9. doi: 10.1038/ng.2367. Epub 2012 Aug 5.
3
The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.一组中国大陆甲状腺毒症性周期性瘫痪患者的临床和遗传特征
BMC Neurol. 2015 Mar 21;15:38. doi: 10.1186/s12883-015-0290-8.
4
Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokalemic paralysis.遗传变异 rs623011(17q24.3)与非家族性毒性弥漫性甲状腺肿及散发性低钾性周期性瘫痪相关。
Clin Chim Acta. 2012 Dec 24;414:105-8. doi: 10.1016/j.cca.2012.08.004. Epub 2012 Aug 15.
5
Genome-wide meta-analysis reveals novel susceptibility loci for thyrotoxic periodic paralysis.全基因组荟萃分析揭示格雷夫斯病周期性瘫痪的新易感位点。
Eur J Endocrinol. 2020 Dec;183(6):607-617. doi: 10.1530/EJE-20-0523.
6
The predisposition to thyrotoxic periodic paralysis (TPP) is due to a genetic variant in the inward-rectifying potassium channel, KCNJ2.甲状腺毒症性周期性瘫痪(TPP)的易感性归因于内向整流钾通道KCNJ2中的一种基因变异。
Clin Endocrinol (Oxf). 2014 May;80(5):770-1. doi: 10.1111/cen.12277. Epub 2013 Jul 31.
7
Association of KCNJ2 Genetic Variants with Susceptibility to Thyrotoxic Periodic Paralysis in Patients with Graves' Disease.KCNJ2基因变异与Graves病患者甲状腺毒症性周期性麻痹易感性的关联
Exp Clin Endocrinol Diabetes. 2017 Feb;125(2):75-78. doi: 10.1055/s-0042-119527. Epub 2016 Dec 22.
8
Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis.非家族性低钾性周期性麻痹的新型易感基因。
Neurology. 2016 Mar 29;86(13):1190-8. doi: 10.1212/WNL.0000000000002524. Epub 2016 Mar 2.
9
Association of genetic variants in GABRA3 gene and thyrotoxic hypokalaemic periodic paralysis in Thai population.泰国人群中GABRA3基因的遗传变异与甲状腺毒症性低钾性周期性麻痹的关联
Clin Endocrinol (Oxf). 2008 Apr;68(4):646-51. doi: 10.1111/j.1365-2265.2007.03083.x. Epub 2007 Oct 29.
10
A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese.一项全基因组关联研究确定PLCL2和AP3D1-DOT1L-SF3A2为日本人心肌梗死的新易感基因座。
Eur J Hum Genet. 2015 Mar;23(3):374-80. doi: 10.1038/ejhg.2014.110. Epub 2014 Jun 11.

引用本文的文献

1
Molecular genetics of skeletal muscle channelopathies.骨骼肌离子通道病的分子遗传学
J Hum Genet. 2025 Aug 6. doi: 10.1038/s10038-025-01370-w.
2
Thyrotoxic periodic paralysis - a retrospective study from Southern India.毒性弥漫性甲状腺肿周期性瘫痪——来自印度南部的回顾性研究。
Eur Thyroid J. 2024 Nov 11;13(6). doi: 10.1530/ETJ-24-0164. Print 2024 Dec 1.
3
Periodic paralysis.周期性瘫痪。
Handb Clin Neurol. 2024;203:39-58. doi: 10.1016/B978-0-323-90820-7.00002-1.
4
Gene panel analysis of 119 index patients with suspected periodic paralysis in Japan.对日本119例疑似周期性瘫痪的索引患者进行基因panel分析。
Front Neurol. 2023 Jan 26;14:1078195. doi: 10.3389/fneur.2023.1078195. eCollection 2023.
5
Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy.离子通道基因突变导致的骨骼肌疾病:发病机制和治疗机会。
Cells. 2021 Jun 16;10(6):1521. doi: 10.3390/cells10061521.
6
Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves' disease patients with thyrotoxic periodic paralysis.一线治疗选择对伴有甲状腺毒症性周期性麻痹的甲状腺功能亢进型格雷夫斯病患者长期预后的影响
J Clin Transl Endocrinol. 2020 Sep 2;21:100235. doi: 10.1016/j.jcte.2020.100235. eCollection 2020 Sep.
7
Further evidence for shared genetic susceptibility in both sporadic and Thyrotoxic periodic paralysis.散发性和甲状腺毒性周期性麻痹共同遗传易感性的进一步证据。
J Neurol Sci. 2020 May 15;412:116794. doi: 10.1016/j.jns.2020.116794. Epub 2020 Mar 20.
8
Assessment of Molecular Subtypes in Thyrotoxic Periodic Paralysis and Graves Disease Among Chinese Han Adults: A Population-Based Genome-Wide Association Study.评估中国汉族成年人甲状腺毒症周期性瘫痪和格雷夫斯病的分子亚型:一项基于人群的全基因组关联研究。
JAMA Netw Open. 2019 May 3;2(5):e193348. doi: 10.1001/jamanetworkopen.2019.3348.
9
Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis.新型长链非编码RNA易感基因及其在甲状腺毒症性周期性瘫痪发病机制中的作用
J Endocr Soc. 2017 Feb 28;1(7):809-815. doi: 10.1210/js.2017-00015. eCollection 2017 Jul 1.
10
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.遗传性离子通道病的治疗方法与药物研发前景
Front Pharmacol. 2016 May 10;7:121. doi: 10.3389/fphar.2016.00121. eCollection 2016.